Search

Author/Creator Elkhashab, Magdy

1. 821Daclatasvir and Asunaprevir Plus Peginterferon Alfa-2a and Ribavirin in Patients With HCV Genotype 1 or 4 Infection: Phase 3 HALLMARK-QUAD Results. (December 2014)

Authors:
Jensen, Donald M.; Sherman, Kenneth; Hezode, Christophe; Pol, Stanislas; Zeuzem, Stefan; De Ledinghen, Victor; Tran, Albert; Elkhashab, Magdy; Younes, Ziad H; Kugelmas, Marcelo; Mauss, Stefan; Everson, Gregory T.; Luketic, Velimir; Vierling, John; Serfaty, Lawrence; Brunetto, Maurizia; Heo, Jeong...
Journal:
Open forum infectious diseases
Issue:
Volume 1(2014)Supplement 1
Page Start:
S234
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase 2, open‐label, randomized, multiple‐dose study evaluating Inarigivir in treatment‐naïve patients with chronic hepatitis B. (11th November 2022)

Authors:
Yuen, Man‐Fung; Chen, Chi‐Yi; Liu, Chun‐Jen; Jeng, Wen‐Juei; Elkhashab, Magdy; Coffin, Carla S.; Kim, Won; Greenbloom, Susan; Ramji, Alnoor; Lim, Young S.; Kim, Yoon J.; Fung, Scott K.; Kim, Dong J.; Jang, Jeong‐Won; Lee, Kwan Sik; Iyer, Radhakrishnan P.; Macfarlane, Chelsea; Jackson, Kathy; Loca...
Journal:
Liver international
Issue:
Volume 43:Number 1(2023)
Page Start:
77
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH. Issue 2 (15th February 2021)

Authors:
Loomba, Rohit; Noureddin, Mazen; Kowdley, Kris V.; Kohli, Anita; Sheikh, Aasim; Neff, Guy; Bhandari, Bal Raj; Gunn, Nadege; Caldwell, Stephen H.; Goodman, Zachary; Wapinski, Ilan; Resnick, Murray; Beck, Andrew H.; Ding, Dora; Jia, Catherine; Chuang, Jen‐Chieh; Huss, Ryan S.; Chung, Chuhan; Subram...
Journal:
Hepatology
Issue:
Volume 73:Issue 2(2021)
Page Start:
625
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. (February 2022)

Authors:
Peyrin-Biroulet, Laurent; Hart, Ailsa; Bossuyt, Peter; Long, Millie; Allez, Matthieu; Juillerat, Pascal; Armuzzi, Alessandro; Loftus, Edward V; Ostad-Saffari, Elham; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Pulley, Jennifer; Lacey, Stuart; Sandborn, William J; Aguilar, Humberto; Ah...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 2(2022)
Page Start:
128
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. (February 2022)

Authors:
Danese, Silvio; Colombel, Jean-Frederic; Lukas, Milan; Gisbert, Javier P; D'Haens, Geert; Hayee, Bu'hussain; Panaccione, Remo; Kim, Hyun-Soo; Reinisch, Walter; Tyrrell, Helen; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Tang, Meina Tao; Schreiber, Stefan; Aboo, Nazimuddin; ...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 2(2022)
Page Start:
118
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. S1126 Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) in Virally Suppressed Chronic Hepatitis B (CHB) Patients With Hepatic Impairment: Week 48 Results From a Phase 2 Open Label Study. (October 2020)

Authors:
Bae, Ho S.; Lim, Young-Suk; Trinh, Huy; Heo, Jeong; Chuang, Wan-Long; Hui, Aric Josun; Elkhashab, Magdy; Tan, Susanna K.; Mo, Shuyuan; Guion, Matthew; Jump, Belinda; Flaherty, John; Suri, Vithika; Gaggar, Anuj; Owen Tsang, Tak Yin; Andreone, Pietro; Janssen, Harry
Journal:
American journal of gastroenterology
Issue:
Volume 115:Supplement(2020)Advances in Inflammatory Bowel Diseases Annual Meeting Abstracts1
Page Start:
S566
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. S1127 Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) in Virally Suppressed Chronic Hepatitis B (CHB) Patients With Renal Impairment: Week 48 Results From a Phase 2 Open-Label Study. (October 2021)

Authors:
Janssen, Harry; Heo, Jeong; Fournier, Claire; Ahn, Sang Hoon; Coffin, Carla S.; 黃, 怡翔; Hui, Aric Josun; Elkhashab, Magdy; Jafri, Syed-Mohammed; Mo, Shuyuan; Winans, Jake; Flaherty, John; Gaggar, Anuj; Chuang, Wan-Long; Gane, Ed J.; Lim, Young-Suk
Journal:
American journal of gastroenterology
Issue:
Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1
Page Start:
S530
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1–6 Hepatitis C Virus Infections and Compensated Liver Disease. (28th March 2019)

Authors:
Gane, Edward; Poordad, Fred; Zadeikis, Neddie; Valdes, Joaquin; Lin, Chih-Wei; Liu, Wei; Asatryan, Armen; Wang, Stanley; Stedman, Catherine; Greenbloom, Susan; Nguyen, Tuan; Elkhashab, Magdy; Wörns, Marcus-Alexander; Tran, Albert; Mulkay, Jean-Pierre; Setze, Carolyn; Yu, Yao; Pilot-Matias, Tami; ...
Journal:
Clinical infectious diseases
Issue:
Volume 69:Number 10(2019)
Page Start:
1657
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗